Chelsie Derman

A study found that migraine-related disability worsens health-related quality of life, with gender-specific differences, particularly affecting women with mild disability.

A year after zuranolone’s FDA approval for postpartum depression on August 3, 2023, prescribers and a patient weigh in about the medication’s success in alleviating symptoms.

A global survey highlights that female patients with psoriatic arthritis experience more tender joints, skin issues, and musculoskeletal tenderness than male patients, emphasizing the need for gender-sensitive treatment approaches.

A recent study sheds light on why women with depression face a greater risk of cardiovascular disease than men, highlighting the need for tailored prevention and management strategies.

A study revealed a significant increase in antidepressant prescriptions among adolescents and young adults during the COVID-19 pandemic, particularly among female adolescents, indicating exacerbation of pre-existing mental health challenges.

A comprehensive study highlighted significant gender-related inequalities in long-term mental health conditions, emphasizing the need for improved healthcare support and inclusivity for transgender, non-binary, and gender-diverse populations.

Participants with poor sleep quality were 85% more likely to have poor cognitive performance on the Stroop test than participants with good sleep quality, a new study found.

Recent research highlights concerns over benzodiazepine use during pregnancy, revealing a heightened risk of miscarriage.

Discover insights from a recent study investigating the potential link between maternal mood disorders and schizophrenia with the risk of type 1 diabetes in children, shedding light on factors impacting early childhood health.